Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Small Cell Lung Carcinoma × Afatinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 39 Neoplasms 20 Squamous Cell Carcinoma of Head and Neck 12 Lung Neoplasms 10 Head and Neck Neoplasms 10 Breast Neoplasms 10 Neoplasm Metastasis 8 Carcinoma, Squamous Cell 5 Stomach Neoplasms 4 Pancreatic Neoplasms 4 Esophageal Squamous Cell Carcinoma 4 Prostatic Neoplasms 3 Glioblastoma 3 Esophageal Neoplasms 3 Colorectal Neoplasms 3 Adenocarcinoma 3 Non-small-cell Lung Cancer With Somatic EGFR Mutations 2 Brain Neoplasms 2 Adenocarcinoma of Lung 2 Urologic Neoplasms 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Thrombocytosis 1 Thoracic Neoplasms 1 Squamous Cell Cancers of the Head and Neck 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Rhabdomyosarcoma 1

Interventions

Etoposide 129 Carboplatin 113 Cisplatin 83 Topotecan 62 durvalumab 43 atezolizumab 39 Irinotecan 38 pembrolizumab 30 Paclitaxel 28 Nivolumab 27 Radiotherapy 25 PM 01183 19 apatinib 18 anlotinib 17 Platinum 16 Drug Therapy 16 Ipilimumab 15 Gemcitabine 15 olaparib 13 Radiosurgery 13 Docetaxel 13 Bevacizumab 12 Pemetrexed 11 toripalimab 10 tislelizumab 9 rovalpituzumab tesirine 9 amrubicin 9 Temozolomide 9 Magnetic Resonance Spectroscopy 9 tremelimumab 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02876081 2017-09-11

THEN

Fondation Hôpital Saint-Joseph

Phase 2 Withdrawn

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡